Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
University of Kentucky
National Cancer Institute (NCI)
BeiGene
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb
Fundación GECP
Checkpoint Therapeutics, Inc.
EpicentRx, Inc.
Novartis
Samsung Bioepis Co., Ltd.
NantCell, Inc.
Humanetics Corporation
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Fox Chase Cancer Center
University of Pittsburgh
SCRI Development Innovations, LLC
Duke University
Massachusetts General Hospital
Mereo BioPharma
Celgene
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
SWOG Cancer Research Network
M.D. Anderson Cancer Center
Eli Lilly and Company
Incyte Corporation
Northwestern University
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Milton S. Hershey Medical Center
Dartmouth-Hitchcock Medical Center
Celgene
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb
PrECOG, LLC.